Compounds > thiotepa
Page last updated: 2024-11-05

thiotepa and Carcinoma, Bronchogenic

thiotepa has been researched along with Carcinoma, Bronchogenic in 9 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MAUER, AM1
KRILL, CE1
DOYLE, E1
CHENAULT, EM1
HOFFMAN, GG1
HARDING, HB1
GRENVILLE-MATHERS, R1
TRENCHARD, HJ1
Livingston, RB1
Perevodchikova, NI1
Bychkov, MB1
Selawry, OS1
Haller, JD1
Bron, KM1
Wholey, MH1
Poller, S1
Enerson, DM1
Denk, W1
Shnider, BI1

Reviews

2 reviews available for thiotepa and Carcinoma, Bronchogenic

ArticleYear
Chemotherapy of solid tumors. Recent advances.
    Postgraduate medicine, 1976, Volume: 59, Issue:2

    Topics: Adult; Alkylating Agents; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinom

1976
Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:2

    Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Carcinoma, Bronchogenic; Cytarabine; Dacti

1973

Other Studies

7 other studies available for thiotepa and Carcinoma, Bronchogenic

ArticleYear
A STUDY OF THE MECHANISMS OF GRANULOCYTOPENIA.
    Annals of the New York Academy of Sciences, 1964, Feb-28, Volume: 113

    Topics: Agranulocytosis; Anemia; Anemia, Macrocytic; Carcinoma; Carcinoma, Bronchogenic; Child; Hodgkin Dise

1964
DOES TREATMENT WITH THIO-TEPA (TRIETHYLENETHIOPHOSPHORAMIDE) PREDISPOSE TO SECONDARY GAS GANGRENE IN PERSONS WITH CARCINOMATOSIS?
    Aerospace medicine, 1964, Volume: 35

    Topics: Carcinoma; Carcinoma, Bronchogenic; Disease Susceptibility; Gas Gangrene; Humans; Pathology; Sepsis;

1964
CYTOTOXIC DRUGS IN BRONCHIAL CARCINOMA.
    Lancet (London, England), 1964, Dec-05, Volume: 2, Issue:7371

    Topics: Alkylating Agents; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Bronchogenic; Cyclophospha

1964
Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:2

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Bronchogenic; Carcino

1973
Selective bronchial artery catheterization for diagnostic and physiologic studies and chemotherapy for bronchogenic carcinoma.
    The Journal of thoracic and cardiovascular surgery, 1966, Volume: 51, Issue:1

    Topics: Adult; Aged; Angiography; Bronchial Arteries; Carcinoma, Bronchogenic; Catheterization; Fluorouracil

1966
[Follow-up therapy with cytostatic drugs following surgery].
    Wiener klinische Wochenschrift, 1966, Jul-22, Volume: 78, Issue:29

    Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Bronchogenic; Cyclophosphamide; Female; Humans; Neoplas

1966
The use of chemotherapy in lung cancer (controlled trials).
    The Medical annals of the District of Columbia, 1971, Volume: 40, Issue:8

    Topics: Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Dactinomycin; Drug Synergism; Female; Fluorouraci

1971